Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer


Korkmaz E. T., KÖKSAL D., Aksu F., DİKMEN Z. G., İÇEN D., Maden E., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.58, ss.15-19, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 58
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.clinbiochem.2018.05.001
  • Dergi Adı: CLINICAL BIOCHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.15-19
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background and aim: Early diagnosis and histological subtyping are important issues in the management of patients with lung cancer (LC). The aim of this study is to investigate the diagnostic value of a panel of serum tumor markers in newly diagnosed patients with LC.